Search Results

• • 8 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer

  Authors:Marc A. Dall'Era, Mary J. Lo, Jaclyn Chen, Rosemary Cress, and Ann S. HamiltonFrom:Cancer (Vol. 124, Issue 9) Peer-Reviewed

  May 1, 2018 Report

   Citation Only

• A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer

  Authors:Helen Chow, Paramita M. Ghosh, Ralph deVere White, Christopher P. Evans, Marc A. Dall'Era, Stanley A. Yap, et al.From:Cancer (Vol. 122, Issue 12) Peer-Reviewed

  June 15, 2016 Report

   Citation Only

• Active surveillance for the management of prostate cancer in a contemporary cohor

  Authors:Marc A. Dall'Era, Badrinath R. Konety, Janet E. Cowan, Katsuto Shinohara, Frank Stauf, Matthew R. Cooperberg, et al.From:Cancer (Vol. 112, Issue 12) Peer-Reviewed

  June 15, 2008 Clinical report

   Citation Only

• Active surveillance for prostate cancer compared with immediate treatment: an economic analysis

  Authors:Kirk A. Keegan, Marc A. Dall'Era, Blythe Durbin-Johnson, and Christopher P. EvanFrom:Cancer (Vol. 118, Issue 14) Peer-Reviewed

  July 15, 2012 Report

   Citation Only

• Contemporary management of muscle-invasive bladder cancer

  Authors:Marc A. Dall'Era, Liang Cheng, and Chong-Xian PanFrom:Expert Review of Anticancer Therapy (Vol. 12, Issue 7) Peer-Reviewed

  July 20127,814 words Report 1480LAuthor(s): Marc A Dall'Era [*] 1 , Liang Cheng 2 , Chong-Xian Pan 3 4 Keywords : bladder urothelial carcinoma; chemotherapy; cisplatin; personalized chemotherapy; targeted therapy Carcinoma of the bladder of...

• Active surveillance for early-stage prostate cancer: review of the current literature

  Authors:Marc A. Dall'Era, Matthew R. Cooperberg, June M. Chan, Benjamin J. Davies, Peter C. Albertsen, Laurence H. Klotz, et al.From:Cancer (Vol. 112, Issue 8) Peer-Reviewed

  Apr. 15, 2008 Disease/Disorder ove...

   Citation Only

• Metastatic signet-ring cell carcinoma of the urinary bladder: a novel management approach to a rare tumour

  Authors:Neil Pugashetti, Stanley A. Yap, Primo N. Lara, Jr., Regina Gandour-Edwards, and Marc A. Dall'EraFrom:Canadian Urological Association Journal (Vol. 9, Issue 4) Peer-Reviewed

  Apr. 20151,750 words Case study 1700LPrimary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the...

• No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period

  Authors:Jennifer N. Wu, Kari M. Fish, Christopher P. Evans, Ralph W. deVere White, and Marc A. Dall'EraFrom:Cancer (Vol. 120, Issue 6) Peer-Reviewed

  Mar. 15, 2014 Report

   Citation Only